Z4P is a BBB-penetrable IRE1 inhibitor with an IC50 of 1.13 µM. Z4P in combination with Temozolomide (HY-17364) inhibits the growth and recurrence of glioblastoma and has anti-tumor activity[1].
Molecular Weight:
312.41
Purity:
99.32
CAS Number:
[2361760-87-2]
Formula:
C19H24N2O2
Target:
IRE1
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted